Cannabinoid Hyperemesis Syndrome Is Becoming More Common in Emergency Departments

A review of cannabinoid hyperemesis syndrome finds increasing ER diagnoses of this condition, which causes severe vomiting in chronic cannabis users and is frequently misdiagnosed as cyclic vomiting syndrome.

Peles, Saar et al.·Cureus·2025·Moderate EvidenceReview
RTHC-07338ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

CHS is characterized by cyclical nausea, vomiting, and abdominal pain in chronic cannabis users, paradoxically caused by a drug known for anti-nausea effects. It is frequently misdiagnosed as cyclic vomiting syndrome. Hot showers/baths provide temporary relief. There has been a steady increase in CHS diagnoses in emergency departments. The pathogenesis is not fully understood but several mechanisms have been proposed.

Key Numbers

Over 100 biologically active cannabinoids in cannabis. CHS diagnoses increasing in emergency departments. Hot water immersion provides temporary symptom relief. Often misdiagnosed as cyclic vomiting syndrome.

How They Did This

Narrative review summarizing the symptoms, pathogenesis, treatments, and differential diagnoses of cannabinoid hyperemesis syndrome, with attention to its increasing prevalence in emergency settings.

Why This Research Matters

As cannabis use increases globally, CHS is becoming a more common reason for emergency department visits. Many patients cycle through multiple ER visits and diagnostic workups before receiving the correct diagnosis, leading to unnecessary costs and continued suffering.

The Bigger Picture

CHS represents one of the clearest examples of how chronic cannabis use can produce paradoxical health effects. The condition challenges the popular perception of cannabis as universally anti-emetic and highlights the importance of clinician awareness as cannabis use becomes more prevalent.

What This Study Doesn't Tell Us

Narrative review without systematic search methodology. The pathogenesis of CHS remains incompletely understood. Prevalence data are limited and likely underestimate the true burden of disease.

Questions This Raises

  • ?What predisposes certain chronic users to develop CHS while others do not?
  • ?Is CHS related to specific cannabis products or consumption methods?
  • ?How quickly do symptoms resolve after complete cessation?

Trust & Context

Key Stat:
CHS diagnoses steadily increasing in emergency departments
Evidence Grade:
Moderate evidence base for CHS as a clinical entity, though the review itself is narrative rather than systematic.
Study Age:
2025 review summarizing current understanding of cannabinoid hyperemesis syndrome.
Original Title:
Cannabinoid Hyperemesis Syndrome: A Rising Complication.
Published In:
Cureus, 17(2), e78958 (2025)
Database ID:
RTHC-07338

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What is cannabinoid hyperemesis syndrome?

CHS is a condition where chronic cannabis users experience cycles of severe nausea, vomiting, and abdominal pain. Paradoxically, it is caused by the same drug that is often used to treat nausea. Hot showers or baths temporarily relieve symptoms. The only known cure is stopping cannabis use.

How is CHS different from cyclic vomiting syndrome?

CHS and cyclic vomiting syndrome share similar symptoms of episodic vomiting, but CHS is specifically linked to chronic cannabis use and resolves with cessation. Misdiagnosis is common, and the key distinguishing factor is a thorough cannabis use history.

Read More on RethinkTHC

Cite This Study

RTHC-07338·https://rethinkthc.com/research/RTHC-07338

APA

Peles, Saar; Khalife, Roy; Magliocco, Anthony. (2025). Cannabinoid Hyperemesis Syndrome: A Rising Complication.. Cureus, 17(2), e78958. https://doi.org/10.7759/cureus.78958

MLA

Peles, Saar, et al. "Cannabinoid Hyperemesis Syndrome: A Rising Complication.." Cureus, 2025. https://doi.org/10.7759/cureus.78958

RethinkTHC

RethinkTHC Research Database. "Cannabinoid Hyperemesis Syndrome: A Rising Complication." RTHC-07338. Retrieved from https://rethinkthc.com/research/peles-2025-cannabinoid-hyperemesis-syndrome-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.